The recent FDA approval of Sculptra for cosmetic use has spawned a renewed interest of the drug in the cosmetic surgery industry and in the media. The Today Show recently featured Sculptra injectable wrinkle filler on a segment of “Today’s Health.” The first half of the segment features a brief treatment demonstration and some patient […]
The so-called liquid facelift has once again been featured by a national media outlet. Harper’s Baazar recently posted an excellent article that outlines the pros and cons of all the latest wrinkle fillers. The Best Beauty section of the September issue includes before and after pictures and a discussion of professional techniques for administering injectables. […]
We wrote last month about the FDA’s recent approval of Sculptra for cosmetic use. Now more physicians are starting to use the wrinkle filler, and marketing efforts of it have been increased. Just recently, Dr. Jeannette Graf appeared on the CBS Early show to demonstrate treatment with Sculptra. This video features a few before and […]
Yesterday brought an exciting announcement from pharmaceutical company sanofi-aventis; Sculptra has been FDA cleared for physicians to use in additional facial cosmetic procedures. Even though off-label cosmetic use of Sculptra is common and has been happening for years, original approval of the filler was for treating lipoatrophy, i.e. facial fat loss, in AIDS patients. Professionals […]
Researchers associated with the American Society for Aesthetic Plastic Surgery (ASAPS) sent questionnaires last March to 687 patients who had received Botox and/or dermal filler treatment. The findings offer some insight about the treatments and the patients who choose them. The following figures illustrate the opinions of the ‘typical’ patient. Who is the ‘typical’ patient? […]
Dysport, the new wrinkle treatment from Medicis, has received FDA approval for treating wrinkles and dystonia. Plastic surgeons and dermatologists could have the drug available in just 3o days. Instead of re-branding the drug ‘Reloxin’ as planned, Medicis Pharmaceutical had to retain its original European name. Along with the April 30th announcement came a 3 […]